Literature DB >> 15740552

Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.

Rey-Heng Hu1, Ming-Chi Ho, Yao-Ming Wu, Seng-Chang Yu, Po-Huang Lee.   

Abstract

BACKGROUND: Recurrence is the most frequent cause of treatment failure after hepatocellular carcinoma (HCC) resection. Salvage liver transplantation is an alternative treatment for recurrent HCC. The transplantability for patients with recurrent HCC has not been well studied. STUDY
DESIGN: This study sought to determine how many patients with recurrent HCC are still candidates for liver transplantation, and to ascertain the possible time from HCC recurrence to the loss of transplantability. In an university hospital setting, 154 of the 252 patients receiving primary HCC resection, from January 1992 through December 1996, had recurrence and were analyzed. The mean follow-up time was 6 years. Among the 154 patients, 74 patients (group 1) were not eligible for liver transplantation according to the Milan criteria, while 80 patients were eligible (group 2). Demographic characteristics of both groups were compared and the curve of transplantability was calculated.
RESULTS: When compared with group 1 patients, group 2 patients displayed more cirrhosis (p = 0.007), lower pTNM stage (p = 0.004), were older (p = 0.004), presented with smaller tumors (p < 0.001), and displayed a longer disease-free interval (p < 0.001). In group 1, only 47% (35/74) patients were eligible for liver transplantation at the time of index hepatectomy, in contrast to 84% (67/80) in the group 2 patients, p < 0.001. The median time from HCC recurrence to the time they were no longer transplantable was 38 months. The total time from the index HCC resection to the time of loss of transplantability was 83 months.
CONCLUSION: In a cohort of patients after resection for their primary HCC, 33% patients had no recurrence and were not in need for liver transplantation in a mean follow-up of 72 months. About 52% of the patients with recurrent HCC still meet the criteria for liver transplantation. For patients with some certain characteristics, resection of the primary HCC may postpone the time of liver transplantation and prolong the time in which a suitable donor searched, while primary liver transplantation may be considered for those patients with factors of low transplantability after recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 15740552     DOI: 10.1111/j.1399-0012.2005.00277.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  11 in total

1.  Laparoscopic repeat resection of recurrent hepatocellular carcinoma.

Authors:  Minggen Hu; Guodong Zhao; Dabin Xu; Rong Liu
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

2.  Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B.

Authors:  Ahmed Hammad; Toshimi Kaido; Kohei Ogawa; Yasuhiro Fujimoto; Tadahiro Uemura; Akira Mori; Etsuro Hatano; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Today       Date:  2015-02-27       Impact factor: 2.549

3.  Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation.

Authors:  Jian Zhou; Zheng Wang; Shuang-Jian Qiu; Xiao-Wu Huang; Jian Sun; Wen Gu; Jia Fan
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-11       Impact factor: 4.553

Review 4.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

5.  Too much of a good thing? When to stop catch-up vaccination.

Authors:  David W Hutton; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2013-07-15       Impact factor: 2.583

6.  Solitary extrahepatic intraabdominal metastasis from hepatocellular carcinoma after liver transplantation.

Authors:  Sae Byeol Choi; Hyungi Kim; Sung Hoon Kim; Young Nyun Park; Kyung Sik Kim
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

Review 7.  Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.

Authors:  William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2010-04-20       Impact factor: 5.344

8.  Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.

Authors:  David W Hutton; Samuel K So; Margaret L Brandeau
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

9.  Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).

Authors:  Richard Bell; Sanjay Pandanaboyana; J Peter A Lodge; K Raj Prasad; Rebecca Jones; Ernest Hidalgo
Journal:  Langenbecks Arch Surg       Date:  2016-07-25       Impact factor: 3.445

Review 10.  Current status of multimodal & combination therapy for hepatocellular carcinoma.

Authors:  Jian Yang; Lunan Yan; Wentao Wang
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.